Boudreaux M K, Dillon A R, Ravis W R, Sartin E A, Spano J S
Department of Pathobiology, College of Veterinary Medicine, Auburn University, AL 36849-5519.
Am J Vet Res. 1991 Dec;52(12):1992-9.
To determine the drug dose required to inhibit platelet reactivity by at least 50%, 2 drug regimens were evaluated in heartworm-negative, heartworm-infected, and heartworm-infected dogs embolized with dead heartworms. Aspirin, or a combination of aspirin and dipyridamole, were administered to 2 groups of Beagles (n = 5 each) for 5 to 9 days; a third group of 5 Beagles served as nontreated controls. For heartworm-negative dogs, mean (+/- SD) aspirin dosage that inhibited collagen-induced platelet reactivity by at least 50% was 6 (+/- 2) mg/kg of body weight given once daily. The aspirin/diphridamole combination dosage was 1 mg of each drug/kg given every 12 hours. All dogs (n = 15) were implanted with 7 adult heartworms each and remedicated (or not treated) beginning at 21 days after heartworm implantation. In heartworm-infected dogs, mean aspirin dosage required to inhibit collagen-induced platelet reactivity greater than or equal to 50% was 10 (+/- 6) mg/kg. Mean dosage of aspirin/dipyridamole combination was 1.6 +/- (0.5) mg of each drug/kg given every 12 hours. When platelet reactivity in response to collagen was determined to be inhibited by at least 50% in all medicated dogs, each dog (n = 15) was embolized with 7 dead adult heartworms to mimic heartworm adulticidal treatment. Platelet reactivity was monitored for 21 days after treatment, and drug dose was adjusted to maintain platelet inhibition by at least 50%. In embolized dogs, mean aspirin dosage was 17 (+/- 14) mg/kg given once daily. Mean dosage of the aspirin/dipyridamole combination was 2.8 (+/- 1.3) mg of each drug/kg given every 12 hours. All dogs (n = 15) were euthanatized 21 days after heartworm embolization. Each lung lobe was evaluated for severity of lesions and presence of organized or fibrinous thrombi. Lesion severity in the aspirin- and aspirin/dipyridamole-treated dogs was not significantly different from that in control dogs.
为确定将血小板反应性抑制至少50%所需的药物剂量,在未感染心丝虫、感染心丝虫以及因死亡心丝虫而发生栓塞的感染心丝虫的犬只中对两种药物方案进行了评估。将阿司匹林或阿司匹林与双嘧达莫的组合给予两组比格犬(每组n = 5),持续5至9天;第三组5只比格犬作为未治疗的对照。对于未感染心丝虫的犬只,将胶原诱导的血小板反应性抑制至少50%的平均(±标准差)阿司匹林剂量为每日一次给予6(±2)mg/kg体重。阿司匹林/双嘧达莫组合剂量为每12小时给予每种药物1 mg/kg。所有犬只(n = 15)均植入7条成年心丝虫,并在植入心丝虫后21天开始重新给药(或不治疗)。在感染心丝虫的犬只中,将胶原诱导的血小板反应性抑制大于或等于50%所需的平均阿司匹林剂量为10(±6)mg/kg。阿司匹林/双嘧达莫组合的平均剂量为每12小时给予每种药物1.6±(0.5)mg/kg。当确定所有用药犬只对胶原的血小板反应性被抑制至少50%时,每只犬(n = 15)用7条死亡成年心丝虫进行栓塞,以模拟心丝虫成虫杀灭治疗。治疗后监测血小板反应性21天,并调整药物剂量以维持血小板抑制至少50%。在栓塞犬只中,平均阿司匹林剂量为每日一次给予17(±14)mg/kg。阿司匹林/双嘧达莫组合的平均剂量为每12小时给予每种药物2.8(±1.3)mg/kg。所有犬只(n = 15)在进行心丝虫栓塞后21天实施安乐死。对每个肺叶评估病变的严重程度以及是否存在机化性或纤维蛋白性血栓。阿司匹林和阿司匹林/双嘧达莫治疗的犬只的病变严重程度与对照犬只无显著差异。